Infectious Disease
News on research and diagnostic development for pathogenic diseases.
UK Government Extends Authorization for Innova Medical SARS-CoV-2 Antigen Test
The UK government has extended the timeline of its Exceptional Use Authorization for the Innova lateral flow test, though the FDA has warned about its performance.
Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test
SARS-CoV-2 testing has become a major part of Co-Diagnostics' business, accounting for the lion's share of the company's revenues recently.
LumiraDx Gets CE Mark for POC, Pooled Sample SARS-CoV-2 Antigen Test
The company last year received FDA Emergency Use Authorization for a PCR-based SARS-CoV-2 that does not require nucleic acid purification or extraction.
DCN Dx Acquires Point-Of-Care Diagnostics Company PortaScience
PortaScience has received 14 small business innovation research grants and commercialized numerous products since its founding in 1999.
Code 1 Supply to Distribute InBios SARS-CoV-2 Antigen Test
The point-of-care test, which received FDA Emergency Use Authorization in May, detects the SARS-CoV-2 nucleoprotein antigen in direct anterior nasal swab specimens.